For these individuals, alternative treatment options, including Radiofrequency (RF) ablation therapy, offer a promising solution. NeuroOne’s OneRF ® ablation system, is the first and only FDA 510 ...

AirHelp Inc. ('AirHelp'), the global leader in air passenger rights and compensation claims management, is excited to announce a significant minority investment from Abry Partners ('Abry'), a leading ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with Acumen Pharmaceuticals (NASDAQ: ABOS) CEO Daniel O ' Connell and Jessica Clark, ...

Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: ...

NeuroOne announced today that it accelerated the anticipated timeline of the FDA submission for its nerve ablation tech.

Technologies accelerated the anticipated timeline of its 510(k) submission to the FDA for trigeminal nerve ablation to ...

Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies ...

EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving ...

(MENAFN- GlobeNewsWire - Nasdaq) EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the ...

Titan Medical has higher revenue and earnings than NeuroOne Medical Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it ...

NeuroOne Medical demonstrated impressive growth in Q1 2025, with product sales reaching a record high. The company’s total revenue surged by 235% compared to the same quarter last year, driven by ...